Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice
Clinical trial NCT02251860 · COMPLETED
Trial details
- NCT number
- NCT02251860
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-05-20
- Primary completion
- 2020-07-23
- Enrollment
- 1454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.